Vitalitus
Vitalitus is a family-owned, Pennsylvania-based supplement company that manufactures pharmaceutical-grade Palmitoylethanolamide (PEA) capsules, topical creams, and combination endocannabinoid formulas for consumers with chronic pain, nerve pain, and inflammation, sold direct-to-consumer online and through wholesale healthcare channels.
- Company typePrivate
- Founded2014
- HeadquartersMars, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Vitalitus does
Vitalitus LLC is a family-owned, privately held American supplement company founded in 2014 and headquartered in Mars, Pennsylvania, that manufactures and sells Palmitoylethanolamide (PEA)-based products for chronic pain, nerve pain, and inflammation management. Its core technology centers on PEA, an endogenous fatty acid amide that acts on PPAR-alpha receptors and has affinity for cannabinoid-like G-coupled receptors GPR55 and GPR119; the company emphasizes pharmaceutical-grade purity, excipient-free formulations, and a patent-pending natural emulsifier (sunflower lecithin) for enhanced bioavailability, with products manufactured in an NSF GMP certified, FDA registered facility and tested via GC-MS, XRF, FTIR, optical microscopy, and microbiological assays.
The product portfolio includes PEA 350mg capsules, a 2% PEA topical cream (Soothamide), a proprietary anandamide combination formula (Anandaplus), a metabolic-support powder (KetoLime, launched 2025), and a Canadian co-developed topical (18 Paths Ultra) blending PEA with traditional eastern botanicals. Vitalitus monetizes through a direct-to-consumer e-commerce storefront on vitalitus.com with auto-ship subscriptions (10% discount), an affiliate program offering 20% commission on retail and 10% on wholesale orders, and a formal wholesale channel serving compounding pharmacies, medical dispensaries, doctor's offices, and health food stores, with international shipping to North America, Europe, Asia Pacific, the Middle East, Latin America, the Caribbean, and Africa.
The company serves individual consumers suffering from chronic pain, CRPS, fibromyalgia, neuropathy, arthritis, and inflammatory conditions, as well as healthcare professionals (physicians, naturopaths, holistic veterinarians) who recommend the products, and a secondary pet-owner segment for animal pain management. Distribution is founder/owner-operated with no disclosed external funding, 11-50 employees, and a small but verified customer-review base (118 reviews at a 4.6 average on the main product line).
Vitalitus firmographics
Firmographics- Name
- Vitalitus
- Legal name
- Vitalitus LLC
- Website
- https://vitalitus.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vitalitus is a family-owned, Pennsylvania-based supplement company that manufactures pharmaceutical-grade Palmitoylethanolamide (PEA) capsules, topical creams, and combination endocannabinoid formulas for consumers with chronic pain, nerve pain, and inflammation, sold direct-to-consumer online and through wholesale healthcare channels.
- Ownership category
- akta.pro rank
Vitalitus industry classification
Industry- Product category
- Dietary Supplements
- NAICS
- Food (Health) Supplement Retailers (456191)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Fats, Oils & Lipid Ingredients (Specialty Oils, MCTs, Structured Lipids) (CRADAOAL)
- akta.pro secondary industries
- Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH), Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL)
Keywords
Where Vitalitus is headquartered
LocationHeadquarters
- HQ city
- Mars
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vitalitus business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Direct Product Sales: One-time purchases of PEA capsules, topical creams, Anandaplus, and bundle packs through e-commerce website with pricing ranging from $12 to $88 per product.
- Auto-Ship Subscriptions: Monthly auto-ship program offering 10% discount on recurring orders. Customers can customize delivery frequency from every 7 days to 180+ days. Can combine subscription with one-time purchases using 'Autoship Companion' coupon code.
- Affiliate Commissions: Affiliates earn 20% commission on retail purchases and 10% on wholesale purchases through referral traffic. Quarterly payment via PayPal.
- Wholesale/B2B Sales: Professional wholesale accounts for compounding pharmacies, medical dispensaries, doctor's offices, and health food stores. Products also available through retail store locator.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Palmitoylethanolamide 350mg capsules - 60 or 120 count bottles |
| Unit Pricing | Pay-as-you-go | Soothamide PEA 2% Topical Cream |
| Unit Pricing | Pay-as-you-go | Anandaplus - Anandamide formula with PEA and OEA |
| Unit Pricing | Pay-as-you-go | Bundle Pack - PEA capsules with Soothamide cream |
| Unit Pricing | Pay-as-you-go | KetoLime - ALCAR with electrolyte blend |
| Unit Pricing | Pay-as-you-go | 18 Paths Ultra - PEA with 18 traditional eastern medicinal plants |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Vitalitus product offering
Product offeringCore offering
Vitalitus manufactures and sells Palmitoylethanolamide (PEA)-based dietary supplements, including 350mg PEA capsules for systemic use, a 2% PEA topical cream (Soothamide), and the Anandaplus anandamide formula, marketed as natural alternatives for chronic pain, nerve pain, and inflammation. Products are sold direct-to-consumer via vitalitus.com with auto-ship subscriptions and wholesale to healthcare providers and retailers.
Product overview
Vitalitus is a family-owned supplement company specializing in N-acylethanolamine products, primarily Palmitoylethanolamide (PEA)-based supplements. The product portfolio centers on three core offerings: Palmitoylethanolamide capsules (350mg) for systemic oral use, Soothamide 2% PEA topical cream for localized application, and Anandaplus (anandamide formula combining PEA and OEA). Additional products include KetoLime (ALCAR + electrolytes for metabolic support) and 18 Paths Ultra (PEA cream with eastern botanicals in menthol base). Products can be purchased individually or as a value bundle combining oral and topical PEA options. The company emphasizes pharmaceutical-grade quality, NSF GMP certification, third-party testing, and domestic (USA) manufacturing.
Differentiator
Problem solved
Functional benefit
Brands
- Anandaplus: Proprietary Anandamide formula with fatty acid amide hydrolase substrates Palmitoylethanolamide and Oleoylethanolamide.
- Soothamide
- KetoLime
- 18 Paths Ultra
Products and services
- Palmitoylethanolamide (PEA) Capsules Pharmaceutical-grade Palmitoylethanolamide supplement in 350mg vegetable capsules (60 or 120 count) with natural rice-based flow agent and sunflower lecithin emulsifier; intended for individuals with chronic pain, nerve pain, and inflammation.
- Soothamide - PEA 2% Topical Cream Topical cream containing 2% Palmitoylethanolamide by weight with soothing botanicals including Myrrh, Frankincense, Shea butter, Aloe Vera, and Jojoba oil; each pump dispenses approximately 20mg of PEA for localized application.
- Anandaplus Proprietary formula containing Palmitoylethanolamide and Oleoylethanolamide as FAAH substrates designed to inhibit N-Acylethanolamine FAAH metabolism and enhance endocannabinoid activity.
- Bundle Pack (PEA Capsules + Soothamide Cream) Customizable bundle pairing Palmitoylethanolamide capsules with Soothamide PEA topical cream for combined systemic and localized anti-inflammatory support at a 10% discount.
- KetoLime Powder supplement combining Acetyl-L-Carnitine (ALCAR) with a balanced electrolyte blend to support natural fat metabolism, mitochondrial energy production, and hydration for keto or low-carb lifestyles.
- 18 Paths Ultra Topical formulation combining Palmitoylethanolamide with 18 traditional eastern medicinal plants in a menthol base, designed for achy muscles and joints with cooling effect combined with longer-lasting PEA action.
Quantifiable outcome
- Zero reported side effects and no drug interactions in clinical literature
- +1 more outcomes
Companies that use Vitalitus
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
Vitalitus technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vitalitus partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 18 Paths (Canadian Partner)minorTeamed up with neighbors to the north (Canada) to combine Vitalitus PEA with 18 traditional eastern medicinal plants in a menthol base for topical formulations. The resulting 18 Paths Ultra products combine quick cooling effects with longer-lasting PEA action.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Vitalitus competitors and assessment
Company assessmentBroad incumbents
- NOW Foods: Large-scale supplement manufacturer and distributor that markets PEA among hundreds of other products. Competes with Vitalitus on price and mass-retail distribution rather than specialization or quality differentiation.
Direct peers
- Doctor's Best: Science-positioned supplement brand selling PEA among other evidence-based ingredients. Comparable to Vitalitus in physician-friendly branding and DTC channel mix, though at significantly broader scale.
- Pure Encapsulations: Practitioner-exclusive supplement brand with a PEA product line and strong purity / hypoallergenic positioning. Most directly comparable to Vitalitus on 'no synthetic excipients' and physician-channel GTM.
- Designs for Health: Practitioner-channel supplement brand emphasizing clinical-grade formulations. Comparable to Vitalitus in its healthcare-provider recommendation strategy and focus on ingredient quality and excipient purity.
- Jarrow Formulas: Specialty supplement brand that markets PEA formulations to health-conscious consumers and healthcare practitioners. Directly comparable in target customer (informed supplement buyers) and product category (PEA capsules).
- Life Extension: Established supplement brand selling Palmitoylethanolamide (PEA) capsules alongside a broad nutraceutical catalog. Competes with Vitalitus directly in the premium PEA category and benefits from larger brand awareness and clinical positioning.
Others
- Elixinol: CBD and endocannabinoid-system-focused brand selling topical creams and ingestible products. Comparable to Vitalitus on endocannabinoid mechanism and topical delivery, though positioned around hemp-derived CBD rather than PEA.
Emerging players
- ProHealth: Specialty supplement retailer long associated with fibromyalgia and chronic fatigue communities, carrying PEA among other pain/inflammation products. Comparable to Vitalitus in patient-community orientation and chronic pain focus.
- Neurobiologix: Specialty nutraceutical brand focused on neurological and inflammatory conditions, including PEA offerings. Comparable to Vitalitus as a smaller, condition-focused competitor targeting similar chronic pain and mast cell patient communities.
- Nootropics Depot: DTC-focused supplement brand with PEA and related endocannabinoid-modulating ingredients. Comparable to Vitalitus in ecommerce-native GTM and biohacker / informed-consumer customer base.
Market position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Vitalitus social profiles
Digital presenceVitalitus compliance and trust
Trust signalCompliance3 records
Vitalitus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitalitus leadership team
Management profileNumber of profiles
Vitalitus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitalitus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitalitus
What does Vitalitus do?
Vitalitus manufactures and sells Palmitoylethanolamide (PEA)-based dietary supplements, including 350mg PEA capsules for systemic use, a 2% PEA topical cream (Soothamide), and the Anandaplus anandamide formula, marketed as natural alternatives for chronic pain, nerve pain, and inflammation. Products are sold direct-to-consumer via vitalitus.com with auto-ship subscriptions and wholesale to healthcare providers and retailers.
Is Vitalitus a public or private company?
Vitalitus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vitalitus founded?
Vitalitus was founded in 2014. It employs 11 to 50 people.
Where is Vitalitus based?
Vitalitus is headquartered in Mars, United States, in the North America region.
How does Vitalitus make money?
Four revenue lines are on record. Direct Product Sales are the primary driver. The others are auto-Ship Subscriptions, affiliate Commissions and wholesale/B2B Sales.
Who are Vitalitus's main competitors?
NOW Foods is listed as a broad incumbent. Direct peers are Doctor's Best, Pure Encapsulations, Designs for Health, Jarrow Formulas and Life Extension. Elixinol is listed as an others. Emerging players are ProHealth, Neurobiologix and Nootropics Depot.
Does Vitalitus have an API?
No public API is recorded for Vitalitus.
What industry is Vitalitus in?
Vitalitus's product category is Dietary Supplements. Its primary akta.pro industry code is CRADAOAL, Fats, Oils & Lipid Ingredients (Specialty Oils, MCTs, Structured Lipids), with a secondary code of HLAMAHAH, Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI). Its NAICS code is 456191 and its SIC code is 2833.